Role of chemokines in atherosclerosis

G Z Feuerstein1, X Wang

  • 1SmithKline Beecham Pharmaceuticals, 709 Swedeland Road, PO Box 1539, UW2523, King of Prussia, PA 19406, USA. Giora_Z_Feuerstein@sbphrd.com

Idrugs : the Investigational Drugs Journal
|May 10, 2008
PubMed

Insights

Chemokines, or chemotactic cytokines, are key drivers of inflammation. This review examines their role in the development and progression of atherosclerotic plaque formation.

Area of Science:

  • Immunology
  • Cardiovascular Biology
  • Cell Biology

Background:

  • Chemokines (chemotactic cytokines) are critical regulators of immune cell trafficking and inflammatory responses.
  • They influence the function of various cell types, including vascular smooth muscle cells, endothelial cells, and macrophages, promoting a pro-inflammatory state.

Purpose of the Study:

  • To critically review the current understanding of chemokines' role in the initiation and progression of atherosclerotic plaque formation.
  • To highlight chemokines as potential therapeutic targets in atherosclerosis.

Main Methods:

  • This is a review article, synthesizing existing research from peer-reviewed literature.
  • Focuses on studies investigating chemokine function in the context of vascular inflammation and atherogenesis.

Main Results:

  • Chemokines are integral to recruiting inflammatory cells to the arterial wall, a key event in early atherosclerosis.
  • They modulate the phenotype of resident vascular cells and infiltrating immune cells, contributing to plaque growth and instability.
  • Specific chemokines and their receptors are implicated in distinct stages of atherosclerotic lesion development.

Conclusions:

  • Chemokines play a pivotal role in both the initiation and progression of atherosclerosis.
  • Targeting chemokine pathways represents a promising strategy for the prevention and treatment of cardiovascular disease.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Inflammation01:38

Inflammation

Overview
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Chemotaxis and Direction of Cell Migration01:21

Chemotaxis and Direction of Cell Migration

Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon towards...